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Red blood cells (RBC) storage facilitates the supply of RBC to meet the clinical demand for transfusion and to avoid
wastage. However, RBC storage is associated with adverse changes in erythrocytes and their preservation medium.
These changes are responsible for functional alterations and for the accumulation of potentially injurious
bioreactive substances. They also may have clinically harmful effects especially in critically ill patients. The clinical
consequences of storage lesions, however, remain a matter of persistent controversy. Multiple retrospective,
observational, and single-center studies have reported heterogeneous and conflicting findings about the effect of
blood storage duration on morbidity and/or mortality in trauma, cardiac surgery, and intensive care unit patients.
Describing the details of this controversy, this review not only summarizes the current literature but also highlights
the equipoise that currently exists with regard to the use of short versus current standard (extended) storage
duration red cells in critically ill patients and supports the need for large, randomized, controlled trials evaluating
the clinical impact of transfusing fresh (short duration of storage) versus older (extended duration of storage) red
cells in critically ill patients.
Keywords: Age of red blood cells, Storage lesion, Critically ill patients, Outcome, Transfusion, Anemia, Trauma,
Cardiac surgery, Mortality, CytokinesIntroduction
Anemia is common in critically ill patients: up to 90% of
patients will be anemic by day 3 of their intensive care
unit (ICU) stay [1,2]. Red blood cells (RBC) transfusion
rates in critically ill patients are reported between 20%
and 40% in ICU [2-4], with a mean of 2 to 5 RBC units
transfused per patient [3,4]. Such anemia of critical
illness has been associated with a poor prognosis even in
the absence of ischemic heart disease [3,5,6]. This associ-
ation supports the value of RBC transfusion in critically ill
patients. Nonetheless, although potentially life-saving for
individual patients, RBC transfusion also has been asso-
ciated with an increased risk of morbidity and/or mortality
in critically ill, surgical, and trauma populations [7,8]. In
this setting, studies have increasingly focused on the
possible deleterious role played by RBC storage dur-
ation (so-called age of red cells) [9-12]. In particular,
they have raised concerns that prolonged RBC storage* Correspondence: cecile.aubron@monash.edu
ANZIC Research Center, School of Public Health & Preventive Medicine,
Monash University, The Alfred Center, 99 Commercial Road, Melbourne, VIC
3004, Australia
© 2013 Aubron et al.; licensee Springer. This is
Attribution License (http://creativecommons.or
in any medium, provided the original work is pmay lead to harm once such “older” red cells are trans-
fused into ICU patients.
To avoid wasting RBC units and improve the provision
of blood stock, standard practice worldwide consists of
transfusing the oldest compatible and available RBC
unit. In addition, RBC can be stored up to 42 days maxi-
mizing their availability and the likelihood that red cells
older than 2 weeks will be transfused into critically ill
patients. This RBC storage duration usually up to 42
days has been defined on the bases of 1) a percentage of
RBC still present in the circulation 24 hours after trans-
fusion higher than 75%, and 2) hemolysis <1% at the end
of the storage period [13]. Despite improved preserva-
tion methods, “storage lesions” occur in such cells,
because in a way that increases over time erythrocytes
develop important biochemical and structural derange-
ments that affect their function and possibly their safety
[10,14].an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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The mean age of blood transfused in ICU patients varies
from 16 to 21 days and is very similar throughout the
world [2,3]. A large range of adverse effects related to
RBC storage have been reported in critically ill patients
when RBC stored for 2 to 4 weeks are transfused. These
include increased mortality [15-22], nosocomial infec-
tions [18,22-27], multiple organ failure [18,28], renal fai-
lure [18,22] deep vein thrombosis [20], increase in ICU
[15] and hospital length of stay (LOS) [29,30], and in
mechanical ventilation duration [18]. Nonetheless, most
clinical studies in this area have been observational in
nature, retrospective in design, small in size, and subject
to bias, leaving this issue unresolved for more than 20
years.
Given the above concerns, further research to deter-
mine the effect of storage lesion (age of red cells) on
clinical outcome in critically ill patients seems impor-
tant. If fresh blood is associated with a decrease of mor-
tality in critically ill patients, changes in transfusion
policies will be applied. Considering the cost and the po-
tential consequences on blood supply of delivery of fresh
blood instead old blood, pivotal trials are required to
answer definitively whether age of blood impacts the
mortality and or morbidity of critically ill patients.
This review will consider: 1) the nature of storage
lesions and why critically ill patients may be especially
susceptible to the adverse effects of prolonged RBC stor-
age; 2) the experimental studies that have explored the
impact of blood storage on tissue oxygenation para-
meters; 3) the clinical studies of the effect of prolongedFigure 1 Changes occurring in red blood cells and storage medium o
diphosphoglycerate; RBC red blood cells.storage in adult trauma, postcardiac surgery, or ICU
patients; and 4) the need for randomized, controlled
studies in this field.
RBC storage lesions
During storage, RBC and their preservative medium suf-
fer metabolic, biochemical, and molecular changes com-
monly referred to as “storage lesion” (Figure 1; Table 1)
[10,31]. Structural RBC changes include depletion of
adenosine triphosphate (ATP) and of 2,3-diphosphogly-
cerate (2,3-DPG); membrane phospholipid vesiculation;
protein oxidation; and lipid peroxidation of the cell
membrane [10,31,32]. Over time, RBC shape changes
with increased osmotic fragility and loss of deformability
[31,33]. Decreased membrane flexibility may comprom-
ise the effect of RBC on microcirculatory flow and parti-
cipates in increasing red cell-endothelial cell interaction,
with activation of inflammatory pathways. Furthermore,
bioreactive substances accumulate in storage medium.
These include 1) lipids that prime recipient neutrophils
and have been implicated in transfusion-related acute
lung injury [34]; 2) cytokines; and 3) free iron from
hemolysis [35].
Recently, a study conducted in healthy volunteers
reported the presence of higher extravascular hemolysis
after older RBC transfusion (storage of 40–42 days)
compared with fresh blood (storage of 3–7 days) illus-
trating the possible harmful effect of iron delivery [36].
This RBC “storage lesion” also alters oxygen delivery
(because of the higher affinity of hemoglobin to oxygen
secondary to a decrease in 2,3-DPG) and pH and, in
addition, it increases cell lysis [10]. Free hemoglobinver the storage time. ATP adenosine triphosphate; 2,3-DPG 2,3-
Table 1 Main biochemical changes in RBC storage medium and in loss of RBC deformability over the storage period
[10,67]
Variables Length of storage
Day 1 Days 7 Days 15 Day 42
K (mmol/L) 3.9 ± 0.6 13.6 ± 1.7 24.5 ± 2.1 46.6 ± 4.1
pH 6.8 ± 0.03 6.74 ± 0.03 6.64 ± 0.02 6.37 ± 0.04
Lactate (mmol/L) 3.6 ± 0.4 7.8 ± 0.7 17.2 ± 2.5 34.5 ± 4.4
Iron (μmol/L) 3.8 ± 0.9 6.8 ± 2.9 7.6 ± 1.6 14.2 ± 2.9
Free hemoglobin (g/L) 1.3 ± 0.5 1.5 ± 0.8 1.7 ± 0.5 3.0 ± 2.1
Percentage of irreversible deformed RBC - 8.4 ± 1.6 14.7 ± 2.6 29.9 ± 4.0
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dysfunction and contributing to intravascular throm-
bosis, vasoconstriction, and leukocyte adhesion [37].
Finally, white blood cells present in the transfused RBC
can increase hemolysis and potassium release, liberate
oxygen radical, and increase erythrocyte alterations
[14,31].
ICU patients may be especially susceptible to
transfusion of older RBC
The severity of illness of blood transfusion recipients may
increase their susceptibility to the deleterious effects of
RBC storage in several ways, making these concerns par-
ticularly relevant to critically ill patients. First, critically ill
patients frequently have disease states that lead to
impaired microcirculatory blood flow [38]. Second, their
neutrophils may be primed by a trigger event (e.g., sepsis
or trauma) and subsequent exposure to bioreactive sub-
stances of RBC unit may initiate enhanced activation of
adherent leucocytes [39]. This hypothetical “two-hit”
model was supported by a study that compared the trans-
fusion of fresh or aged RBC into healthy rats with lipo-
polysaccharide pretreated rats. Transfusion of aged
erythrocytes caused mild pulmonary inflammation but no
coagulopathy in healthy rats, while it augmented lung in-
jury by inducing coagulopathy in lipopolysaccharide pre-
treated rats. This difference was not found with the
transfusion of fresh blood [39]. ICU patients are likely to
undergo invasive mechanical ventilation (MV). Experi-
mental data report an increase of transfusion related acute
lung injury in mice receiving MV compared with those
without MV. MV, particularly with injurious ventilator
setting, induces lung injury and increase susceptibility of
TRALI [40].
Finally, a “dose-effect” may exist and, because critically
ill patients are especially susceptible to receiving mul-
tiple transfusions, this effect may increase their risk of
developing adverse events [20,41]. In addition, receiving
multiple transfusions will increase the risk that at least
one of the RBC units transfused will be “old.” In a retro-
spective study, Weinberg et al. found an independent
increase in the risk of death when trauma patientsreceived 6 or more RBC units with at least one RBC
stored for ≥14 days [16]. The same authors, in 1,647
trauma patients transfused within the first 24 hours
postinjury, reported a higher independent risk of death
only in patients who received 3 or more units stored for
≥14 days (RR = 1.57, 95% CI 1.14-2.15, p = 0.01) [41].
RBC storage and tissue oxygenation parameters
In critically ill patients, RBC transfusion is commonly
used to restore or increase tissue oxygenation. Different
surrogate markers of tissue oxygenation have been used
to explore the relationship between duration of RBC
storage and their efficacy in restoring optimal tissue oxy-
genation. In 1993, Marik et al. were the first to report a
harmful effect of duration of RBC storage on systemic
and tissue oxygenation. In 23 mechanically ventilated
septic patients, they prospectively demonstrated an in-
verse association between change in gastric intramucosal
pH (reflecting oxygen uptake) and age of blood [42].
Nonetheless, this was a post-hoc analysis and such a re-
lationship was not confirmed in three subsequent studies
[43-45]. One of these negative studies was a double-
blind, randomized trial that compared the effect of RBC
transfusion on tonometric indexes when RBC units were
stored less than 5 days versus more than 20 days. This
study did not show any difference between the study
groups. Furthermore, there was no benefit from trans-
fusing RBC whatever the age of blood possibly because
of the defined transfusion target (80–90 g/L) or because
the poor sensitivity of the tonometric technique [44].
More recently, Sakr et al. did not find any impact of
storage time on sublingual microvascular perfusion in a
prospective, single-center, observational study conducted
in 35 patients with severe sepsis and septic shock [45].
In the setting of severe traumatic brain injury, the im-
pact of RBC storage duration on cerebral oxygenation
assessed by brain tissue oxygen pressure (PtiO2) was re-
cently studied in an observational prospective study [46].
RBC stored for more than 19 days were unable to
increase brain oxygenation, whereas fresh blood (<19
days) was effective [46]. In light of the contradictory
findings of these five in vivo studies, it remains
Table 2 Studies reporting a clinically harmful effect of prolonged RBC storage
Authors Year Setting N Study
design
Main confounders used for
adjustment








No No Median of RBC storage was
lower in survivors (17 days)
than in nonsurvivors (median










Patient age, serum lactate, base
deficit
No Mean age of RBC >14 days
associated with MOF (OR 1.16,
CI 95%, 1.01-1.34, p = 0.03)
Vamvakas
et al. [23]
1999 Post-CABG 416 Retrospective
single-center
Chronic systemic illness, CABG
surgery type, IABP, intubation,
impaired consciousness, patient age,
bypass time, chest tube drainage,
admission WBC count
No Oldest blood was associated
with a higher risk of
pneumonia and/or wound
infection compared with fresh
blood (median of the mean
age of the oldest and second
oldest RBC units = 21.6 (range:
4–41) days vs. 13 (range: 2–39)
days, p = 0.0002)
Offner
et al. [26]
2002 Trauma, ≥ 6






Patient age, ISS, gender, mechanism
of injury
No Risk of major infectious
complications increased with
the number of RBC units >14
days (OR = 1.13, 95% CI, 1.01-
1.26, p = 0.03)
Keller et al.
[29]
2002 Trauma with up
to 4 RBC units





ISS, requirement for surgery, volume
of RBC, patient age
No Association between the









Re-intubation, central nervous system
dysfunction, Apache II score, MV
duration
No Association between older
RBC (>28 days) and the risk of
pneumonia (OR = 1.06, 95%




2005 Trauma 275 Retrospective
single-center
Patient age, ISS, leukodepletion
volume of RBC
95% Association between older
blood and longer ICU and
hospital LOS (RR = 1.15, 95%








Baseline characteristics Mixed Old blood >14 days was





2008 Trauma, ≥ 1





Patient age, gender, ISS, mechanism
of injury, volume of RBC, hospital LOS
Yes Transfusion ≥6 RBC units of












Patient age, gender, ISS, presence of
thoracic injury, MV, volume of RBC
Yes RBC ≥14 days was associated
with mortality (OR = 1.12, 95%
CI: 1.02 to 1.23), renal failure
(OR = 1.18, 95% CI, 1.07-1.29)
and pneumonia (OR = 1.10,




2010 Trauma, ≥1 RBC




Patient age, gender, ISS, mechanism
of injury, volume of RBC,FFP and
platelets, presence of head injury
Yes 3 or more RBC ≥14 days
increased risk of death (RR =








Patient age, cryoprecipitate, Glasgow
coma score, ISS
Mixed Association between RBC >21
days and DVT occurrence
Association between RBC >28
days and mortality (OR = 4,
95% CI, 1.34-11.61)
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Table 2 Studies reporting a clinically harmful effect of prolonged RBC storage (Continued)
Vandrome
et al. [27]
2009 Trauma 487 Retrospective
single-center
Patient age, gender, ISS, mechanism
of injury and MV time
Yes Risk of pneumonia higher in
patients transfused with RBC










Volume of RBC, procedures details,
demographic characteristics
NG Increased in age of the
youngest RBC was associated
with 30-day mortality (HR =













Yes Hospital mortality higher
when the oldest RBC >31 days
compared with RBC <10 days







Place of surgery, patient age gender,
BMI, preoperative Hb, diabetes,
reoperation due to bleeding, use of
cardiopulmonary bypass,
concomitant valve surgery,
comorbidities, volume of RBC and
platelets units, ABO blood group
Mixed Higher risk of severe
postoperative infections (OR =
2.5, 95% CI, 1.2-4.2) in patients
with RBC exclusively ≥14 days
Pettila
et al. [15]
2011 ICU 757 Prospective
multicenter
observational
Apache III score, leukodepletion
status, pre-ICU transfusion, cardiac
surgery, other transfused blood
components, pretransfusion Hb
preceding the first transfusion,
centers
80% Oldest RBC associated with




2012 Trauma 196 Retrospective
single-center
ISS, head trauma, surgery, use for
SDD, volume of RBC and of platelets
Yes Patients with infections
received more old blood (>14
days) than patients without
infections (8 RBC units (range:
2–16) versus 4 RBC units
(range: 2–8), p = 0.02)
RBC red blood cells; ICU intensive care unit; LOS length of stay; MV mechanical ventilation; DVT deep vein thrombosis; ARDS acute respiratory distress syndrome;
CABG coronary artery bypass graft; MOF multi organ failure; IABP intra-aortic balloon pump; WBC White blood cells; ISS injury severity score; APACHE II score Acute
Physiology and Chronic Health Evaluation II score; RR relative risk; BMI body mass index; Hb hemoglobin; FFP fresh frozen plasma; SDD selective digestive
decontamination, NG not given.
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RBC to modulate tissue oxygenation.
RBC storage and clinical outcome - Review
We searched with the PubMed database studies compa-
ring clinical outcomes of critically ill patients receiving
fresh or old blood. Excluding non-English language reports
and studies conducted in pediatric patients, we identified
32 studies that examined the clinical effect of blood sto-
rage in trauma patients, ICU patients, and patients under-
going cardiac surgery or those with acute heart disease
[15-30,41,47-59]. Eighteen of these studies reported a dele-
terious effect of increasing duration of RBC storage on
clinically relevant outcomes [15-30,41] (Table 2), whereas
14 of these studies did not demonstrate any effect of
prolonged RBC storage (Table 3) [47-59].
Positive studies
ICU patients
Two of the 18 positive studies were conducted in ICU
patients [15,16]. The first was retrospective and under-
powered and was conducted in 31 patients with severe
sepsis or septic shock, and without adjustment forconfounding factors [16]. The second was a recent, pro-
spective, multicenter, observational study conducted in
47 Australian and New Zealand ICUs. This study en-
rolled 757 patients and found a significant increase in
ICU LOS and in-hospital mortality rate in patients
receiving the oldest blood (median of age = 17.6 days,
range: 12.9-24.0) versus the freshest (median of age =
7.5 days, range: 5.7-9.0; OR = 2.01, 95% confidence
interval [CI]: 1.07-3.77). This effect was seen after
adjustment for severity of illness (APACHE III score),
number of transfusions, pre-ICU transfusions, fresh-
frozen plasma and platelet transfusions, leukodepletion
status, pretransfusion hemoglobin concentration, clus-
tering of study sites, and cardiac surgery [15]. Figure 2
illustrates the association between hospital mortality and
maximum age of RBC found by these authors. However,
in this observational study, patients received a mix of
blood of different age (e.g., fresh and old units) and the
statistical analysis could only use a surrogate of age of
blood (fresh or old) received by the patients, by using
the age of the oldest RBC unit as the unit as representa-
tive of age of red cell transfused for statistical assessment
of their effect.
Table 3 Studies reporting no clinical effect of prolonged RBC storage
Author Year Setting N Study design Adjustment for confounders Leukodepletion Outcome and main results
Wasser
et al. [47]
1989 Post- CABG 237 Single-center
randomized Cases:
RBC<12 hours; controls:
RBC stored for 2 to 5
days
NA No No difference in bleeding and
RBC transfusion requirement,
nonetheless the platelets
counts and thrombotest were









days; “Old group”: RBC
>20 days





2000 Post- CABG 268 Retrospective single-
center
Gender, patient age,
comorbidities, type of CABG,
IABP, duration of anaesthesia,
time on bypass, other surgery,
repeated surgery, chest tube
drainage volume
No Post-operative ICU LOS,







APACHE III score, Tidal volume,
thrombocytopenia, massive
transfusion
70% Median storage duration of
the oldest RBC unit = 20.3
days (range: 16–31) in
absence of ALI versus 20.1























center study Cases: RBC
<18 days Controls:
standard cares
Year of surgery, volume of
transfusion, duration of
surgery, previous CABG,
number of distal anastomoses,
patient age, gender, Hb at
admission


















NG Patients with ALI (median of
average RBC storage = 22.9
days (range: 17–31) versus
22.9 days (range: 15–30) in

















2010 ICU 298 Retrospective single-
center
Volume of RBC, patient age,








2011 ICU 126 Prospective single-
center observational











Volume of RBC, baseline and
patient characteristics
Yes Early post-operative mortality,
post-operative MV >72h, renal
failure, infections, 30 day
mortality, hospital mortality,
prolonged MV, new renal
failure, infectious










redo cardiac surgery, pre-
operative Hb, emergency
Yes Mortality
Aubron et al. Annals of Intensive Care 2013, 3:2 Page 6 of 11
http://www.annalsofintensivecare.com/content/3/1/2
Table 3 Studies reporting no clinical effect of prolonged RBC storage (Continued)
operation, perioperative MI,
Re-exploration, year of








center Cases: one fresh
RBC unit (<5 days)
Control: one RBC unit of
standard practices
NA Yes Change in PaO2/FiO2 ratio, in
peak and plateau airway
pressures, in markers of
immune status and in
coagulation
NA not applicable; RBC red blood cell; ICU intensive care unit; LOS length of stay; MV mechanical ventilation; DVT deep vein thrombosis; ALI acute lung injury;
CABG coronary artery bypass graft, APACHE III score Acute Physiology and Chronic Health Evaluation III score; Hb hemoglobin; MI myocardial infarction; FFP fresh-
frozen plasma; SOFA Sequential Organ Failure Assessment; NG not given.
*Blood stored up 35 days and not 42 days.
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In the setting of cardiac surgery or acute cardiovascular
heart diseases, six positive studies have been published.
Of these, two were prospective [19,24] and four were
retrospective [18,21,23,25]. Their methods and their pri-
mary results are summarized in Table 2. Three of them
have reported an increased incidence of postoperative
infections in patients who were transfused with the ol-
dest blood [23-25]. The largest study was conducted by
Koch et al. and included 6,002 patients undergoing co-
ronary artery bypass graft (CABG) and/or valve surgery
[18]. Patients who received exclusively “oldest” blood
defined by a storage duration longer than 14 days had
longer duration of mechanical ventilation (9.7% vs. 5.6%,
p < 0.001), an increased incidence of sepsis (4% vs. 2.8%,
p = 0.01) and a higher 1-year mortality rate (11% vs.
7.4%, p < 0.001). Transfusion of older RBC also was
independently associated with an increased risk-adjusted
rate of a composite of serious adverse events (25.9% vs.
22.4%, p = 0.001) [18]. Despite a large sample size, this
study suffered important limitations, including a retro-
spective and single-center design, the use of an arbitrary
cutoff point to define fresh and old blood, and theFigure 2 Hospital mortality (%, 95% confidence interval) according to
with permission.absence of adjustment for some important confounding
factors [60]. Two other reports, however, considered
patients with heart disease also found an impact of RBC
storage on mortality [19,21]. One, a retrospective multi-
center study reported that the age of the youngest RBC
transfused within 10 days of percutaneous coronary
intervention was significantly associated with 30-day
mortality after adjustment for confounders (HR = 1.02,
95% CI 1.18-1.34, p < 0.001) [21]. The other found a li-
near relationship between the age of blood and mortality
in 4,933 cardiovascular disease patients in acute care
facilities [19].
Trauma patients
In trauma patients, ten studies have reported an impact
of the storage duration on mortality and/or morbidity
[17,20,22,26-30,41]. All were retrospective, single-center
studies. Trauma patients transfused with blood older
than 14 days appeared to have a higher risk of develo-
ping postinjury multiorgan failure [28], infectious com-
plications [22,26,27,61], renal dysfunction [22], greater
LOS [29], and higher mortality [17,22,41]. Regardless of
the arbitrary cutoff of 14 days to define fresh and oldmaximum age of red blood cells (days) from Pettila et al. [15]
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blood storage duration and hospital LOS [30], occur-
rence of deep vein thrombosis [20], and mortality
[20,30]. Trauma patients are more likely to receive a
“massive” transfusion and, as already mentioned, a dose
effect of oldest blood may exist [17,20,27,41].
Despite these positive observational studies, the evi-
dence for a harmful effect of blood storage remains
uncertain. This is because few of these reports adjusted
for key confounding factors, including leukodepletion,
volume of RBC transfused, the year of transfusion, and
ABO type, and very few analyzed RBC age as a continu-
ous variable [60]. None adjusted for all key confounders.
Negative studies
In contrast to the above-mentioned investigations, 14
studies did not find any relationship between blood storage
duration and mortality, ICU and hospital LOS, duration of
mechanical ventilation, acute lung injury, nosocomial
infection, renal failure, or deep vein thrombosis occur-
rence (Table 3) [47-59,62].
ICU patients
One of the seven studies conducted in ICU patients was a
double-blind, multicenter, randomized pilot study that
enrolled 57 patients and compared a composite outcome,
including mortality, between patients who received only
blood of less than 8 days of age versus standard care. The
small sample size (n = 57) likely contributed to an incon-
clusive result [51]. Taylor et al. reported an independent
increase of nosocomial infection after blood transfusion in
a prospective, observational study of 449 ICU patients but
did not find any effect of age of RBC [53]. Three reports
have especially studied the impact of RBC age on acute
lung injury (ALI) or short-term pulmonary function in
critically ill patients and did not find any difference
[50,54,62]. Similarly, no effect of age of blood on deep vein
thrombosis, ICU LOS, and mortality was found in two re-
cent studies of ICU patients [56,57]. All of these studies
were small and likely underpowered.
Cardiovascular patients
In postcardiac surgery patients, one of the six negative
studies conducted more than 20 years ago was a single-
center, randomized, controlled, blind trial that compared
post-CABG bleeding in 237 patients who received either
2 units of freshly collected whole blood (fresher than 12
hours) followed by blood stored between 2 and 5 days or
blood aged between 2 and 5 days. In this nonpragmatic
study, there was no difference for bleeding and RBC
transfusion requirements [47].
All the other negative, postcardiac surgery studies
were retrospective and single center in design. Nonethe-
less, some had a large sample size [52,58,59]. Forexample, in a 2,732 patient cohort, Van de Watering
et al. did not show any difference in 30-day survival,
ICU, and hospital LOS between patients receiving fresh
blood versus old blood, whatever the criteria to estimate
the storage duration (only blood < or > 18 days, the
mean RBC storage time for each patient, the storage
time of the youngest RBC transfused per patient, and
the storage time of the oldest RBC transfused per pa-
tient) [52]. Similar results were reported by Yap et al.
who did not find any association between RBC storage
duration estimated by the mean age of RBC per patient,
the oldest RBC unit and RBC stored longer than 30
days, and early postoperative mortality or morbidity
in 670 post cardiac surgery patients [55]. Van Straten
et al. also reported no association between the risk of
early and late mortality and the age or the number of
RBC units transfused during or within the 5 first days
post-CABG [59].
Trauma patients
The only negative study in trauma patients was an
underpowered (n = 17) single-center, randomized trial
that was conducted between 2000 and 2001. The study
design required 15 compatible RBC units of both study
arms to be available at randomization, which impacted
the study feasibility [48].
Need for randomized, controlled trials
As outlined earlier, studies that evaluated the clinical
impact of RBC storage in critically ill patients were 1)
heterogeneous in outcomes, study design, population,
threshold to differentiate fresh and old blood, and blood
characteristics (leukodepleted or not, different storage
medium, or storage medium not documented) and 2)
often of insufficient quality in methodology (retrospect-
ive, observational, small sample size, no or limited inclu-
sion of key confounding factors, and arbitrary cutoff for
age of blood).
Their inherent limitations do not allow confirmation
of the potential impact of duration of RBC storage on
adverse effects or justify a change in current clinical
transfusion practice. Two of the four randomized, con-
trolled trials (RCTs) that evaluated clinical outcomes
were very small and underpowered [48,51]. The third
had a protocol based on the hypothesis that extremely
fresh blood (<12 hours) may contain functionally active
platelets and coagulation factors and decrease postsur-
gery bleeding [47], and the most recent RCT only
focused on the age and effect of a single RBC unit with
mainly pulmonary complications as outcome [62].
Previous systematic reviews [9-11,13] and a meta-
analysis conducted in critically ill patients [63] have been
inconclusive. Recently, in a meta-analysis, including 21
studies, Wang et al. concluded that older stored blood
Figure 3 Length of blood storage for positive (a
[15,16,18,23,27,28,61]) and negative (b, [50-55,58,62]) studies. The
age of blood is expressed as the mean age or the median age of all
RBC units, or in some studies as the median of the oldest (or oldest
and second oldest) RBC units. The figures give the age of blood for
each study comparing the primary study outcome. For instance, if
the study outcome is TRALI, the figure shows the age of blood in
the group of patients with TRALI and in the group of patients
without TRALI.
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(95% CI 1.07-1.24). However, some studies did not ad-
just the risk of death for important confounders , mak-
ing their conclusions open to challenge [12]. In addition,
definition of fresh and old blood remains based on
observational studies and therefore unknown because of
the heterogeneity of their results (Figures 3a and b).
The above observations make a large, multicenter, RCT
in critically ill patients of the greatest priority [64]. In thisTable 4 Multicenter, randomized, clinical trials about blood s
Authors or study name Population Sample
size
Case c
Hebert et al. [51] ICU 57 <8 day
Aubron et al. [67] ICU 51 Freshes
availab
**RECESS (NCT00991341) Post cardiac surgery 1434 ≤10 da







RECESS, Red Cell Storage Duration Study; ABLE, Age of Blood Evaluation; TRANSFUS
carE; MODS multiorgan dysfunction score; **Indicates the trial is in progress.
*Included hospital mortality, serious nosocomial infections, thrombotic events withregard, several such multicenter RCTs are currently under-
way in adult critically ill patients (Table 4) [65].
The first such trial is the RECESS (Red Cell Storage
Duration Study [RECESS]: NCT00991341) study. RE-
CESS will randomize 1,434 cardiac surgical patients to
receive either RBC stored 10 days or less or 21 days or
more. However, its results could not be generalizable to
any heterogeneous ICU population.
The Canadian ABLE study (Age of Blood Evaluation
[ABLE] trial of the resuscitation of critically ill patients:
ISRCTN44878718) is currently being conducted in ICU
patients. It will enroll a total of 2,510 patients in Canada,
France, and the United Kingdom [66]. The ABLE study
will compare 90-day mortality between patients trans-
fused with fresh RBC (defined as a storage duration
<8 days) and patients transfused in accordance with
standard practices [66]. Potential limitations of ABLE
include 1) a sample size based on an estimated 25% rela-
tive risk reduction in the primary endpoint and 2) a de-
sign (fresh blood always fresher than 8 days) that seems
unlikely to be reproducible always in future clinical
practice.
The TRANSFUSE trial (ACTRN12612000453886) com-
mences in 2012 in Australia and New Zealand. TRANS-
FUSE is a large (5,000 patients) pivotal, multicenter,
randomized, controlled trial in critically ill patients to
determine whether, compared with standard care, transfu-
sion of the freshest available RBC decreases patient mor-
tality. Completion is expected in 2015 and its findings are
likely to guide blood transfusion policy in ICU patients.
Conclusions
Blood transfusion is a common therapeutic intervention
in critically ill patients. Much scientific evidence, how-
ever, supports the occurrence of alterations in red cells
over their storage time, and observational studies sug-
gest that transfusion of older RBC may have important
adverse clinical consequences, including mortality in this
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http://www.annalsofintensivecare.com/content/3/1/2transfusion policy to deliver only fresh red cells to critic-
ally ill patients would have far-reaching logistics. The
possibility that a clinically significant risk of older RBC
transfusion exists and the possible benefits of making
adjustments to transfusion policy can only be resolved
by supporting and completing the current, pivotal, mul-
ticenter, double-blind RCTs. Until such trials are
reported, any clinical practice change is premature.
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